Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (301-310 of 1,137) with videos related to

Pageof 114
Sort By:
The American Journal of Cardiology|October 3, 2002
Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarctionSabina A Murphy, Christopher Chen, Christopher P Cannon, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2014
The risk of seizures among the carbapenems: a meta-analysisJoan P Cannon, Todd A Lee, Nina M Clark, et al.
American Heart Journal|January 31, 2006
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyEric E Smith, Christopher P Cannon, Sabina Murphy, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
International Journal of Antimicrobial Agents|November 24, 2004
Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospitalUrsula Changela, Joan P Cannon, Chinyere Aneziokoro, et al.
Journal of the American College of Cardiology|August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapyChristopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.
Clinical Cardiology|December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.
The American Journal of Cardiology|October 11, 2018
WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia ManagementChristie M Ballantyne, Deepak L Bhatt, Christopher P Cannon, et al.
Critical Pathways in Cardiology|February 17, 2012
Are continuing medical education activities effective in improving the competence and performance of clinicians? Evidence from activities for primary care clinicians who manage patients with acute coronary syndromesJanardhan Sampath, Derek T Dietze, Peter P Toth, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 2005
Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in spinal-cord-injury patients with chronic indwelling cathetersPalak S Shah, Joan P Cannon, Christine L Sullivan, et al.
Pageof 114

Showing results (301-310 of 1,137) with videos related to

Sort By:
Pageof 114
The American Journal of Cardiology|October 3, 2002
Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarctionSabina A Murphy, Christopher Chen, Christopher P Cannon, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2014
The risk of seizures among the carbapenems: a meta-analysisJoan P Cannon, Todd A Lee, Nina M Clark, et al.
American Heart Journal|January 31, 2006
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyEric E Smith, Christopher P Cannon, Sabina Murphy, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
International Journal of Antimicrobial Agents|November 24, 2004
Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospitalUrsula Changela, Joan P Cannon, Chinyere Aneziokoro, et al.
Journal of the American College of Cardiology|August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapyChristopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.
Clinical Cardiology|December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.
The American Journal of Cardiology|October 11, 2018
WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia ManagementChristie M Ballantyne, Deepak L Bhatt, Christopher P Cannon, et al.
Critical Pathways in Cardiology|February 17, 2012
Are continuing medical education activities effective in improving the competence and performance of clinicians? Evidence from activities for primary care clinicians who manage patients with acute coronary syndromesJanardhan Sampath, Derek T Dietze, Peter P Toth, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 22, 2005
Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in spinal-cord-injury patients with chronic indwelling cathetersPalak S Shah, Joan P Cannon, Christine L Sullivan, et al.
Pageof 114